Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers

• Status: Completed
• Trial end date: 2016-04-01

Summary

The main purpose is to determine the pharmacokinetics (PK) of Triferic iron administered orally in healthy adult volunteers. It is a randomized multiple treatments, single dose study.

• Phase: Phase 1

Details

• Lead Sponsor: Rockwell Medical Technologies, Inc.
• Treatments: Citric Acid; Iron; Pharmaceutical Solutions; Sodium Citrate